Back to search results

Randomized Trial of SGLT2i in Heart Transplant Recipients

Abroad (travel likely)RecruitingPHASE4

Conditions

Heart Transplant · Cardiovascular Disease · Kidney Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto, California, United States

    Contact: Study coordinator (Karim Sallam, MD) · Karim.Sallam@va.gov · 650-493-5000

  • Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville, Tennessee, United States

    Contact: Study coordinator (Henry Ooi, MD) · henry.ooi@va.gov · 615-327-4751

  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas, United States

    Contact: Study coordinator (Savitri E Fedson, MD) · savitri.fedson@va.gov · 713-791-1414

  • VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City, Utah, United States

    Contact: Study coordinator (Heather Hanson, AAS BS) · Heather.Hanson@va.gov · 801-582-1565
    Contact: Principal Investigator (Josef Stehlik, MD MPH)

  • Hunter Holmes McGuire VA Medical Center, Richmond, VA, Richmond, Virginia, United States

    Contact: Study coordinator (Neil Lewis, MD) · neil.lewis@va.gov · 804-675-5000

  • William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison, Wisconsin, United States

    Contact: Study coordinator (David R Murray, MD) · david.murray@va.gov · 608-256-1901
Study leads

  • Josef Stehlik, MD MPH

    Principal Investigator

    VA Salt Lake City Health Care System, Salt Lake City, UT

View source on ClinicalTrials.gov(opens in a new tab)